Free Virtual Conference – Precision Oncology Spring

Precision Oncology had a tremendous boost with the 2015 roll-out of the Precision Medicine Initiative. What started with a focus on next generation gene sequences for the cancer genome has blossomed into a full set of tools for assaying solid and liquid tumors and the consequent development of analytical assays, analysis software platforms, and precision therapies – biologics, vaccines, and small-molecules.

Nowhere has precision oncology been more useful than in developing innovative technologies for tumor heterogeneity. Precision Oncology has benefited from, first, precision sequencing of populations of cells and, second, through development of small drugs and biologics that alone or in combination have boosted the efficacy of therapies. Further, innovations in cell-based therapies (NK cell, CAR-T cell therapies) are in clinical trials; in fact, CAR-T cell therapies have been approved by FDA for selected cancer cases.

Come join us for the Precision Oncology Virtual Summit to hear from leaders in academia, biotech, pharma, diagnostics, clinical research, healthcare, and regulatory bodies on this topic!

With all this innovation in full swing, you cannot miss the line-up of speakers who will address these topics and more:

Clinical data in the era of Precision Oncology
Biomarker/Genetics/Genomics Platforms
Clinical and gene-based assays
Novel therapies for cancer – biologics, vaccines, small molecules, and combination therapies
Cell-based therapies and scale-up
Identification and stratification strategies for oncology clinical trials
Positioning drugs tied to pharmacogenetics for coverage by payers
Tracking and evaluating data through telehealth for rapid collections of clinical trial data
Who should attend:

Executives and Decision Makers – CEOs, CTOs, CMOs, and CSOs
Leaders in clinical genomics, biomarkers, assays
Clinical trial planning and operations
Clinical Research, Development, Translational Medicine
Practicing Clinicians
Genomics/Genetics Analysts
Regulatory Leaders in Government and Business Affairs groups
Economic Planners and Forecasters
Marketing Leaders
Business Development Managers
Biotech and Biomedical technology researchers
Government and public support agencies